Literature DB >> 35233724

The impact of lifestyle intervention on left atrial function in type 2 diabetes: results from the DIASTOLIC study.

Aseel Alfuhied1,2,3, Gaurav S Gulsin1,2, Lavanya Athithan1,2, Emer M Brady1,2, Kelly Parke1,2, Joseph Henson1,2,4, Emma Redman1,2,4, Anna-Marie Marsh1,2, Thomas Yates1,2,4, Melanie J Davies4, Gerry P McCann1,2, Anvesha Singh5,6.   

Abstract

Aerobic exercise training and low energy diets have been shown to improve left ventricular remodelling and diastolic function in adults with type 2 diabetes (T2D), albeit with differential effects. The impact of these lifestyle interventions on left atrial (LA) function, however, has not previously been reported. The DIASTOLIC study was a prospective, randomised, open-label, blind endpoint trial, in which 90 people with obesity and T2D and no prevalent cardiovascular disease were randomised to a 12-week intervention of: (i) routine care, (ii) aerobic exercise training, or (iii) low energy (≈ 810 kcal/day) meal replacement plan (MRP). Cardiac magnetic resonance (CMR) imaging was performed pre- and post-intervention. Image analysis included LA volumes (LAV), emptying fraction (LAEF), and LA strain (LAS) corresponding to LA reservoir (LAS-r), conduit (LAS-cd), and booster pump (LAS-bp) function. 73 participants with T2D (mean age 50 ± 6 years, 62% male, body mass index (BMI) 36.1 ± 5.3 kg/m2) completed the trial and had analysable LA images. There was no significant change in CMR measured LA volumetric function (LAV/LAEF) in any group. The routine care group showed no significant change in BMI or LAS. In the MRP group, there were significant reductions in BMI (4.5 kg/m2) and a significant increase in LAS-r and LAS-bp (29.9 ± 7.0 to 32.3 ± 7.0%, p = 0.036 and 14.6 ± 5.3 to 17.2 ± 3.7%, p = 0.034). The exercise group showed a small reduction in BMI (0.49 kg/m2), with no significant change in LAS. Compared to routine care, weight loss via a 12-week MRP, led to improvements in LA filling and contractile function in adults with T2D and obesity. However, these within-group changes were not statistically significant on between-group comparison. ClinicalTrials.gov Identifier: NCT02590822.
© 2022. The Author(s).

Entities:  

Keywords:  Cardiac magnetic resonance imaging; Left atrium; Lifestyle; Type 2 diabetes

Year:  2022        PMID: 35233724     DOI: 10.1007/s10554-022-02578-z

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  43 in total

1.  Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden.

Authors:  Teresa S M Tsang; Marion E Barnes; Bernard J Gersh; Kent R Bailey; James B Seward
Journal:  Am J Cardiol       Date:  2002-12-15       Impact factor: 2.778

2.  Left atrial dysfunction in type 2 diabetes mellitus: insights from cardiac MRI.

Authors:  Bruno Graça; Maria João Ferreira; Paulo Donato; Leonor Gomes; Miguel Castelo-Branco; Filipe Caseiro-Alves
Journal:  Eur Radiol       Date:  2014-07-17       Impact factor: 5.315

3.  Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

Authors:  Sherif F Nagueh; Otto A Smiseth; Christopher P Appleton; Benjamin F Byrd; Hisham Dokainish; Thor Edvardsen; Frank A Flachskampf; Thierry C Gillebert; Allan L Klein; Patrizio Lancellotti; Paolo Marino; Jae K Oh; Bogdan Alexandru Popescu; Alan D Waggoner
Journal:  J Am Soc Echocardiogr       Date:  2016-04       Impact factor: 5.251

4.  Role of diabetes in congestive heart failure: the Framingham study.

Authors:  W B Kannel; M Hjortland; W P Castelli
Journal:  Am J Cardiol       Date:  1974-07       Impact factor: 2.778

5.  Early detection of left atrial strain abnormalities by speckle-tracking in hypertensive and diabetic patients with normal left atrial size.

Authors:  Sergio Mondillo; Matteo Cameli; Maria Luce Caputo; Matteo Lisi; Elisabetta Palmerini; Margherita Padeletti; Piercarlo Ballo
Journal:  J Am Soc Echocardiogr       Date:  2011-06-12       Impact factor: 5.251

Review 6.  Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology.

Authors:  Petar M Seferović; Mark C Petrie; Gerasimos S Filippatos; Stefan D Anker; Giuseppe Rosano; Johann Bauersachs; Walter J Paulus; Michel Komajda; Francesco Cosentino; Rudolf A de Boer; Dimitrios Farmakis; Wolfram Doehner; Ekaterini Lambrinou; Yuri Lopatin; Massimo F Piepoli; Michael J Theodorakis; Henrik Wiggers; John Lekakis; Alexandre Mebazaa; Mamas A Mamas; Carsten Tschöpe; Arno W Hoes; Jelena P Seferović; Jennifer Logue; Theresa McDonagh; Jillian P Riley; Ivan Milinković; Marija Polovina; Dirk J van Veldhuisen; Mitja Lainscak; Aldo P Maggioni; Frank Ruschitzka; John J V McMurray
Journal:  Eur J Heart Fail       Date:  2018-03-08       Impact factor: 15.534

7.  Diabetic cardiomyopathy--fact or fiction?

Authors:  B Maisch; P Alter; S Pankuweit
Journal:  Herz       Date:  2011-03       Impact factor: 1.443

8.  Changes in left atrial volume in diabetes mellitus: more than diastolic dysfunction?

Authors:  Krishna Kishor Kadappu; Anita Boyd; Suzanne Eshoo; Brian Haluska; Anthony E T Yeo; Thomas H Marwick; Liza Thomas
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2012-04-27       Impact factor: 6.875

Review 9.  Left Atrial Structure and Function, and Left Ventricular Diastolic Dysfunction: JACC State-of-the-Art Review.

Authors:  Liza Thomas; Thomas H Marwick; Bogdan A Popescu; Erwan Donal; Luigi P Badano
Journal:  J Am Coll Cardiol       Date:  2019-04-23       Impact factor: 24.094

Review 10.  Diabetic cardiomyopathy: prevalence, determinants and potential treatments.

Authors:  Gaurav S Gulsin; Lavanya Athithan; Gerry P McCann
Journal:  Ther Adv Endocrinol Metab       Date:  2019-03-27       Impact factor: 3.565

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.